Recruiting Crohns Disease Studies in Chicago
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
This is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease....
Treatment of Moderate to Severe Refractory Crohn's Disease
This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to le...
About Crohns Disease Clinical Trials in Chicago
Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.
There are currently 2 crohns disease clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 214 participants. Research is being sponsored by AstraZeneca, Tr1X, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Crohns Disease Clinical Trials in Chicago — FAQ
Are there crohns disease clinical trials in Chicago?
Yes, there are 2 crohns disease clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What crohns disease treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.
Data updated March 2, 2026 from ClinicalTrials.gov